{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:50:44Z","timestamp":1767981044019,"version":"3.49.0"},"reference-count":16,"publisher":"Codon Publications","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergologia et Immunopathologia"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.aller.2017.10.005","type":"journal-article","created":{"date-parts":[[2018,3,17]],"date-time":"2018-03-17T04:14:26Z","timestamp":1521260066000},"page":"322-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Assessment of IL-31 levels and disease severity in children with atopic dermatitis"],"prefix":"10.15586","volume":"46","author":[{"given":"D.","family":"Ozceker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Celik","family":"Ozbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Dilek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Koser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Tamay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Guler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6228","reference":[{"key":"10.1016\/j.aller.2017.10.005_bib0085","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI21060","article-title":"New insights into atopic dermatitis","volume":"113","author":"Leung","year":"2004","journal-title":"J Clin Invest"},{"issue":"Suppl","key":"10.1016\/j.aller.2017.10.005_bib0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hanifin","year":"1980","journal-title":"Acta Dermatol Venereol (Stockh)"},{"key":"10.1016\/j.aller.2017.10.005_bib0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1034\/j.1600-0625.2002.110102.x","article-title":"Pathophysiology of pruritus in atopic dermatitis: an overview","volume":"11","author":"Stander","year":"2002","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.aller.2017.10.005_bib0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11882-014-0423-y","article-title":"Interleukin-31: a novel diagnostic marker of allergic diseases","volume":"14","author":"Rabenhorst","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.aller.2017.10.005_bib0105","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.aller.2017.10.005_bib0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2340\/00015555-1191","article-title":"IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis","volume":"92","author":"Nobbe","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.aller.2017.10.005_bib0115","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","article-title":"A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1","volume":"133","author":"Cevikbas","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2017.10.005_bib0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/all.12316","article-title":"Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge","volume":"69","author":"Hawro","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.aller.2017.10.005_bib0125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2017.10.005_bib0130","doi-asserted-by":"crossref","first-page":"e0161877","DOI":"10.1371\/journal.pone.0161877","article-title":"IL-31-driven skin remodeling involves epidermal cell proliferation and thickening that lead to impaired skin-barrier function","volume":"11","author":"Singh","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.aller.2017.10.005_bib0135","doi-asserted-by":"crossref","first-page":"468","DOI":"10.5021\/ad.2011.23.4.468","article-title":"IL-31 serum protein and tissue mRNA levels in patients with atopic dermatitis","volume":"23","author":"Kim","year":"2011","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.aller.2017.10.005_bib0140","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1468-3083.2010.03794.x","article-title":"Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring","volume":"25","author":"Ezzat","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.aller.2017.10.005_bib0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1399-3038.2011.01241.x","article-title":"IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis","volume":"23","author":"Raap","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.aller.2017.10.005_bib0150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5114\/pdia.2013.38356","article-title":"Correlation between serum interleukin-31 level and the severity of disease in children with atopic dermatitis","volume":"30","author":"Siniewicz-Luze\u0144czyk","year":"2013","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.aller.2017.10.005_bib0155","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3345\/kjp.2015.58.3.96","article-title":"Relationship between serum 25-hydroxyvitamin D and interleukin-31 levels, and the severity of atopic dermatitis in children","volume":"58","author":"Cheon","year":"2015","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.aller.2017.10.005_bib0160","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jaci.2006.07.015","article-title":"Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis","volume":"118","author":"Neiss","year":"2006","journal-title":"J Allergy Clin Immunol"}],"container-title":["Allergologia et Immunopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054618300090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054618300090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T17:18:30Z","timestamp":1693588710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301054618300090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0301054618300090"],"URL":"https:\/\/doi.org\/10.1016\/j.aller.2017.10.005","relation":{},"ISSN":["0301-0546"],"issn-type":[{"value":"0301-0546","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of IL-31 levels and disease severity in children with atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Allergologia et Immunopathologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aller.2017.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 SEICAP. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}